- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Singleton-Merten Syndrome in United States
Total 14293 results
-
Onconova Therapeutics, Inc.Withdrawn
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedMyelodysplastic SyndromesUnited States
-
Opsona Therapeutics Ltd.M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaboratorsCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Rush University Medical CenterH. Lundbeck A/STerminatedMyelodysplastic SyndromeUnited States
-
Arno TherapeuticsUnknown
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic SyndromeUnited States
-
Veeda OncologyCephalonTerminatedMyelodysplastic SyndromeUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndromes | Hematologic DiseasesUnited States
-
Neurological Associates of West Los AngelesActive, not recruitingNeuralgia | Complex Regional Pain Syndromes | Thoracic Outlet Neurologic SyndromeUnited States
-
University of CincinnatiNational Heart, Lung, and Blood Institute (NHLBI); Rare Diseases Clinical Research...CompletedBirt-Hogg-Dube SyndromeUnited States
-
University of NebraskaEli Lilly and CompanyTerminatedShort Bowel SyndromeUnited States
-
ShireTakeda Development Center Americas, Inc.Active, not recruiting
-
Milton S. Hershey Medical CenterGlaxoSmithKline; The American Society of Cataract and Refractive Surgery FoundationCompleted
-
Mayo ClinicCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Sirion Therapeutics, Inc.CompletedDry Eye SyndromesUnited States
-
University of New MexicoWithdrawn
-
AllerganCompletedDry Eye SyndromesUnited States
-
AllerganCompleted
-
AllerganCompletedDry Eye SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
Washington University School of MedicineSunesis PharmaceuticalsCompletedMyelodysplastic SyndromesUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloproliferative Neoplasm | Myelodysplastic Neoplasm | Pathway Mutant Myelodysplastic SyndromesUnited States
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Alliance for Cancer Gene TherapyTerminatedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Merkel Cell Carcinoma | Metastatic Merkel Cell Carcinoma | Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage IIIA Cutaneous Merkel... and other conditionsUnited States
-
Gillette Children's Specialty HealthcareTerminatedDravet Syndrome | Lennox-Gastaut SyndromeUnited States
-
Uma BorateRecruitingTherapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
National Institute of Arthritis and Musculoskeletal...Completed
-
Lindsey Russell, MDNapo Pharmaceuticals, Inc.Not yet recruitingShort Bowel SyndromeUnited States
-
ReGenTree, LLCCompletedAssessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2Dry Eye SyndromeUnited States
-
Boston Children's HospitalEntrinsic Bioscience Inc.TerminatedShort Bowel SyndromeUnited States
-
Le Bonheur Children's HospitalUniversity of Tennessee Health Science CenterUnknown
-
University of Colorado, DenverNo longer available
-
Children's Hospital Medical Center, CincinnatiApproved for marketingDravet SyndromeUnited States